Tricuspid valve replacement with the St. Jude Medical valve

Abstract

A study was conducted on 20 patients who underwent tricuspid valve replacement (TVR) with the St. Jude Medical (SJM) valve. Isolated TVR was performed on 9 patients, and additional mitral, or mitral and aortic valve replacements were performed on 11 patients. Four patients (20%) died in the early postoperative period, but there were no deaths related to the SJM valve in the tricuspid position. The mean follow-up period of the 16 survivors was 74.4 months, and there have been no deaths during the follow-up period. The postoperative actuarial survival rate was 80%, 10 years after surgery. Three patients, representing 0.25%/patient-months, developed valve thrombosis, the valve thrombosis-free rate being 72.8%, 10 years after surgery, while entrapment of a leaflet by endothelial pannus was found in one patient, representing 0.08%/patient-months. Thus, the incidence of all prosthetic valve-related complications was 0.34%/patient-months, and the postoperative complication-free rate was 65.3%, 10 years after surgery. The medium-term follow-up study of TVR with the SJM valve revealed no prosthetic valve-related deaths and a relatively low incidence of prosthetic valve-related complications. However, as with other mechanical valves, valve thrombosis was a major risk posed by the SJM valve in the tricuspid position.

Prospectively Randomized Comparison of Different Mechanical Aortic Valves

“…Various reports on the clinical course after AVR indicate a similar outcome for most mechanical aortic valves. [13][14][15][16][17][18][19][20][21][22] However, most series include only 1 or sometimes 2 different valves. To date, no prospectively randomized comparison has been performed to evaluate different bileaflet MHVs.…”

An Evaluation of Left Ventricular Function after Surgery for Pure Mitral Regurgitation Using Dobutamine-stress Echocardiography. Should the Mitral Complex Be Preserved?

“…We used SJM valves in all patients who underwent MVR. It is well known that the SJM valve is a reliable, durable valve prosthesis with excellent hemodynamic function and low incidence of thromboembolic events [8][9][10][11]. Our satisfactory results may be produced from that reason.…”

“…It is well known that postoperative LV function of MVP is superior to MVR. However, MVP depend on th Meanwhile, MVR also had good results over a 10 year period [8][9][10][11] according to the recent advancement of prosthetic valves. To avoid postoperative low cardiac output syndrome, Lillehei et al [12] began to replace diseased mitral valves while preserving the posterior leaflet, chordae and papillary muscles in 1962.…”

Successful Planned Pregnancy in a Patient With St Jude Medical Prosthetic Mitral Valve

“…6 It has several hemodynamic features with a bileaflet central-flow design, a lower transvalvular pressure gradient and total pyrolytic carbon resistant thrombogenicity. 6 Long-term results have demonstrated an excellent hemodynamic performance and a low incidence of valve-related complications. 6 We report here our successful planned delivery in a patient with a SJM heart valve in the mitral position and review the the literature.…”

“…6 Long-term results have demonstrated an excellent hemodynamic performance and a low incidence of valve-related complications. 6 We report here our successful planned delivery in a patient with a SJM heart valve in the mitral position and review the the literature.…”